Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.78307304 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.63104039 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.63104039 |
4 | modulation by symbiont of host immune response (GO:0052553) | 5.63104039 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.63104039 |
6 | modulation by symbiont of host defense response (GO:0052031) | 5.63104039 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.63104039 |
8 | neutrophil activation involved in immune response (GO:0002283) | 5.35097499 |
9 | macrophage activation involved in immune response (GO:0002281) | 4.89378742 |
10 | negative regulation of cell killing (GO:0031342) | 4.80254466 |
11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.80254466 |
12 | response to peptidoglycan (GO:0032494) | 4.71837549 |
13 | microglial cell activation (GO:0001774) | 4.61131566 |
14 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.58667694 |
15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.46791613 |
16 | respiratory burst (GO:0045730) | 4.45509903 |
17 | detection of bacterium (GO:0016045) | 4.23053253 |
18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.21332648 |
19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.14314982 |
20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10023485 |
21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02694174 |
22 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.98550722 |
23 | granulocyte activation (GO:0036230) | 3.86191449 |
24 | superoxide anion generation (GO:0042554) | 3.82687240 |
25 | neutrophil activation (GO:0042119) | 3.82052987 |
26 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.77595047 |
27 | macrophage activation (GO:0042116) | 3.75002243 |
28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.73979320 |
29 | cellular extravasation (GO:0045123) | 3.70743665 |
30 | response to host immune response (GO:0052572) | 3.70058529 |
31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.70058529 |
32 | immunoglobulin mediated immune response (GO:0016064) | 3.65730731 |
33 | cellular response to type I interferon (GO:0071357) | 3.65482871 |
34 | type I interferon signaling pathway (GO:0060337) | 3.65482871 |
35 | detection of biotic stimulus (GO:0009595) | 3.64146101 |
36 | response to type I interferon (GO:0034340) | 3.63349093 |
37 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.58550172 |
38 | myeloid cell activation involved in immune response (GO:0002275) | 3.54061551 |
39 | positive regulation of interferon-alpha production (GO:0032727) | 3.51663647 |
40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.50617202 |
41 | B cell mediated immunity (GO:0019724) | 3.49963445 |
42 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.48708515 |
43 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.46211788 |
44 | defense response to protozoan (GO:0042832) | 3.45800645 |
45 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.44672365 |
46 | positive regulation of mast cell degranulation (GO:0043306) | 3.44672365 |
47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.43787700 |
48 | positive regulation of B cell differentiation (GO:0045579) | 3.42707227 |
49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.36498804 |
50 | regulation of interferon-alpha production (GO:0032647) | 3.35285087 |
51 | positive regulation of mast cell activation (GO:0033005) | 3.34616005 |
52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.32499697 |
53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29835594 |
54 | positive regulation of antigen processing and presentation (GO:0002579) | 3.29634363 |
55 | detection of molecule of bacterial origin (GO:0032490) | 3.27896401 |
56 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.27823635 |
57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.26455006 |
58 | response to protozoan (GO:0001562) | 3.25940759 |
59 | regulation of mast cell degranulation (GO:0043304) | 3.25099223 |
60 | reactive oxygen species biosynthetic process (GO:1903409) | 3.24220713 |
61 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23393597 |
62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.22415384 |
63 | response to host (GO:0075136) | 3.21701446 |
64 | response to host defenses (GO:0052200) | 3.21701446 |
65 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21701446 |
66 | pinocytosis (GO:0006907) | 3.09083267 |
67 | neutrophil mediated immunity (GO:0002446) | 3.08740005 |
68 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08450430 |
69 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.08176460 |
70 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07734478 |
71 | I-kappaB phosphorylation (GO:0007252) | 3.06650683 |
72 | regulation of mononuclear cell migration (GO:0071675) | 3.06287728 |
73 | N-acetylneuraminate metabolic process (GO:0006054) | 3.04996387 |
74 | negative regulation of interleukin-12 production (GO:0032695) | 3.04709750 |
75 | lipoxygenase pathway (GO:0019372) | 3.03099969 |
76 | regulation of B cell differentiation (GO:0045577) | 3.01963258 |
77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01185580 |
78 | positive regulation of type 2 immune response (GO:0002830) | 3.00338836 |
79 | regulation of mast cell activation (GO:0033003) | 2.98533122 |
80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97690814 |
81 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97503847 |
82 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96685441 |
83 | positive thymic T cell selection (GO:0045059) | 2.96058902 |
84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.91674291 |
85 | cellular response to interferon-gamma (GO:0071346) | 2.90670032 |
86 | amino sugar catabolic process (GO:0046348) | 2.89548741 |
87 | response to muramyl dipeptide (GO:0032495) | 2.88191884 |
88 | T-helper 1 type immune response (GO:0042088) | 2.87406864 |
89 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.87318861 |
90 | regulation of T cell tolerance induction (GO:0002664) | 2.86821028 |
91 | eosinophil chemotaxis (GO:0048245) | 2.85584748 |
92 | myeloid dendritic cell differentiation (GO:0043011) | 2.85028281 |
93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.81710134 |
94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80998784 |
95 | neutrophil chemotaxis (GO:0030593) | 2.80571318 |
96 | myeloid dendritic cell activation (GO:0001773) | 2.80331798 |
97 | positive regulation of lymphocyte migration (GO:2000403) | 2.79460663 |
98 | regulation of antigen processing and presentation (GO:0002577) | 2.79247130 |
99 | regulation of monocyte chemotaxis (GO:0090025) | 2.78840047 |
100 | NIK/NF-kappaB signaling (GO:0038061) | 2.78696070 |
101 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77178636 |
102 | detection of other organism (GO:0098543) | 2.76911896 |
103 | regulation of platelet activation (GO:0010543) | 2.76109107 |
104 | negative regulation of interleukin-17 production (GO:0032700) | 2.75062094 |
105 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.74996518 |
106 | neutrophil migration (GO:1990266) | 2.73530447 |
107 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.73148773 |
108 | regulation of tolerance induction (GO:0002643) | 2.72546073 |
109 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.71559325 |
110 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.71474200 |
111 | positive regulation of leukocyte degranulation (GO:0043302) | 2.71171417 |
112 | eosinophil migration (GO:0072677) | 2.71068419 |
113 | myeloid leukocyte activation (GO:0002274) | 2.70883407 |
114 | response to interferon-gamma (GO:0034341) | 2.70678968 |
115 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.70370587 |
116 | positive regulation of acute inflammatory response (GO:0002675) | 2.69809658 |
117 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.68972047 |
118 | complement activation, alternative pathway (GO:0006957) | 2.67288527 |
119 | lymphocyte chemotaxis (GO:0048247) | 2.66697378 |
120 | detection of external biotic stimulus (GO:0098581) | 2.66546693 |
121 | regulation of leukocyte degranulation (GO:0043300) | 2.65964804 |
122 | T cell migration (GO:0072678) | 2.64599781 |
123 | leukotriene metabolic process (GO:0006691) | 2.63044739 |
124 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.60815560 |
125 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.60620809 |
126 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59487253 |
127 | regulation of lymphocyte migration (GO:2000401) | 2.59323323 |
128 | granulocyte chemotaxis (GO:0071621) | 2.59221602 |
129 | leukocyte mediated cytotoxicity (GO:0001909) | 2.59107427 |
130 | germinal center formation (GO:0002467) | 2.58033980 |
131 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.57458247 |
132 | monocyte chemotaxis (GO:0002548) | 2.57005267 |
133 | leukocyte aggregation (GO:0070486) | 2.56185947 |
134 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.55797657 |
135 | B cell receptor signaling pathway (GO:0050853) | 2.54191189 |
136 | phagocytosis, engulfment (GO:0006911) | 2.54056562 |
137 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.52966683 |
138 | cytokine secretion (GO:0050663) | 2.52207545 |
139 | granulocyte migration (GO:0097530) | 2.51659023 |
140 | response to fungus (GO:0009620) | 2.51332939 |
141 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.49093568 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.30348495 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.63209497 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.18940487 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.03390609 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65112157 |
6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.27812215 |
7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87829519 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.69694266 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.48285713 |
10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45970823 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37031693 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36051746 |
13 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.29219373 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15872822 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 2.12365080 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11811409 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10526039 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06614977 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.06114129 |
20 | MAF_26560356_Chip-Seq_TH1_Human | 2.04987948 |
21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.01653958 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95304263 |
23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.92603807 |
24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.90585060 |
25 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.81340913 |
26 | MYB_26560356_Chip-Seq_TH1_Human | 1.79850505 |
27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77262827 |
28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76082378 |
29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73556287 |
30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72378915 |
31 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65893639 |
32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64382072 |
33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62931449 |
34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62467368 |
35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61667600 |
36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59891116 |
37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59254980 |
38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58729737 |
39 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58556030 |
40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57567787 |
41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51252553 |
42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49365057 |
43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48420325 |
44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48049454 |
45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47611650 |
46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46954153 |
47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45421939 |
48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44855787 |
49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42957004 |
50 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.40484841 |
51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38499995 |
52 | MAF_26560356_Chip-Seq_TH2_Human | 1.36278956 |
53 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32338565 |
54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29746371 |
55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26939562 |
56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26238880 |
57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25576830 |
58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25231307 |
59 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25038759 |
60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24999327 |
61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23850001 |
62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19849154 |
63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19513736 |
64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19044422 |
65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18626108 |
66 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18465236 |
67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17778223 |
68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16661342 |
69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15032238 |
70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10688192 |
71 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.10374327 |
72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09444660 |
73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08692881 |
74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08434423 |
75 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07349357 |
76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07025157 |
77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07024767 |
78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06711567 |
79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04059240 |
80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03784809 |
81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03784809 |
82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03089004 |
83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01047972 |
84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01046860 |
85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00610781 |
86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00514254 |
87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00333124 |
88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99008797 |
89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98984542 |
90 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97549273 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97330455 |
92 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96661851 |
93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96028884 |
94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95785558 |
95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94485672 |
96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94370161 |
97 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91691648 |
98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90779773 |
99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90609385 |
100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90395510 |
101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90058311 |
102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90051181 |
103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89244926 |
104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88475705 |
105 | MYB_26560356_Chip-Seq_TH2_Human | 0.87770760 |
106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87467095 |
107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87325934 |
108 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85734725 |
109 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85391828 |
110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85203639 |
111 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.84401946 |
112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84330665 |
113 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.83844949 |
114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82395919 |
115 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.81266583 |
116 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80229734 |
117 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.80064180 |
118 | VDR_22108803_ChIP-Seq_LS180_Human | 0.79916096 |
119 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.79251789 |
120 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.79248130 |
121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78302625 |
122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77749263 |
123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77042104 |
124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76909791 |
125 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76652495 |
126 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.76152679 |
127 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.76002925 |
128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.75863120 |
129 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75506685 |
130 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75287916 |
131 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.75278712 |
132 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74176076 |
133 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.74060597 |
134 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.73672894 |
135 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.73100306 |
136 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.72982147 |
137 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.72803220 |
138 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.72577066 |
139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72435443 |
140 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72232807 |
141 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72041422 |
142 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.71154221 |
143 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70654333 |
144 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.70608469 |
145 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70510706 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.24499051 |
2 | MP0003436_decreased_susceptibility_to | 3.64646999 |
3 | MP0003303_peritoneal_inflammation | 3.50960191 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.42764862 |
5 | MP0002419_abnormal_innate_immunity | 3.41875853 |
6 | MP0005058_abnormal_lysosome_morphology | 3.37387952 |
7 | MP0003724_increased_susceptibility_to | 3.35684900 |
8 | MP0006082_CNS_inflammation | 3.25860920 |
9 | * MP0005000_abnormal_immune_tolerance | 3.04131118 |
10 | MP0009785_altered_susceptibility_to | 2.96029802 |
11 | MP0005025_abnormal_response_to | 2.74993045 |
12 | MP0001790_abnormal_immune_system | 2.64718613 |
13 | MP0005387_immune_system_phenotype | 2.64718613 |
14 | * MP0002452_abnormal_antigen_presenting | 2.49541101 |
15 | MP0003690_abnormal_glial_cell | 2.46689417 |
16 | MP0003172_abnormal_lysosome_physiology | 2.40999818 |
17 | MP0009840_abnormal_foam_cell | 2.39690532 |
18 | * MP0001800_abnormal_humoral_immune | 2.39012160 |
19 | * MP0002723_abnormal_immune_serum | 2.28666584 |
20 | MP0003191_abnormal_cellular_cholesterol | 2.22933413 |
21 | MP0005464_abnormal_platelet_physiology | 2.21335675 |
22 | MP0005671_abnormal_response_to | 2.18670380 |
23 | MP0001533_abnormal_skeleton_physiology | 2.09079241 |
24 | * MP0001819_abnormal_immune_cell | 1.95281244 |
25 | * MP0002420_abnormal_adaptive_immunity | 1.95110273 |
26 | MP0000685_abnormal_immune_system | 1.88107018 |
27 | MP0004510_myositis | 1.84947487 |
28 | MP0009764_decreased_sensitivity_to | 1.84761203 |
29 | MP0001853_heart_inflammation | 1.82684999 |
30 | MP0003075_altered_response_to | 1.75265029 |
31 | * MP0001845_abnormal_inflammatory_respons | 1.70192592 |
32 | MP0008469_abnormal_protein_level | 1.69285360 |
33 | MP0000604_amyloidosis | 1.68522407 |
34 | MP0003763_abnormal_thymus_physiology | 1.67268691 |
35 | * MP0002405_respiratory_system_inflammati | 1.65447802 |
36 | MP0000920_abnormal_myelination | 1.64458362 |
37 | MP0000343_altered_response_to | 1.64223655 |
38 | MP0002998_abnormal_bone_remodeling | 1.55794185 |
39 | MP0005451_abnormal_body_composition | 1.44149170 |
40 | MP0008260_abnormal_autophagy | 1.38998809 |
41 | MP0005360_urolithiasis | 1.38249549 |
42 | MP0005167_abnormal_blood-brain_barrier | 1.35762426 |
43 | MP0005397_hematopoietic_system_phenotyp | 1.34901243 |
44 | MP0001545_abnormal_hematopoietic_system | 1.34901243 |
45 | MP0003195_calcinosis | 1.34751761 |
46 | MP0001851_eye_inflammation | 1.33026204 |
47 | MP0004947_skin_inflammation | 1.32127346 |
48 | MP0010155_abnormal_intestine_physiology | 1.30705177 |
49 | MP0005166_decreased_susceptibility_to | 1.29902067 |
50 | * MP0000716_abnormal_immune_system | 1.29790977 |
51 | MP0002277_abnormal_respiratory_mucosa | 1.25774828 |
52 | MP0003136_yellow_coat_color | 1.22787218 |
53 | MP0005164_abnormal_response_to | 1.22303013 |
54 | MP0002138_abnormal_hepatobiliary_system | 1.19825352 |
55 | MP0003448_altered_tumor_morphology | 1.19676558 |
56 | MP0003183_abnormal_peptide_metabolism | 1.18606661 |
57 | MP0002139_abnormal_hepatobiliary_system | 1.17288704 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.15680513 |
59 | MP0005174_abnormal_tail_pigmentation | 1.14342495 |
60 | MP0009763_increased_sensitivity_to | 1.12129040 |
61 | MP0002933_joint_inflammation | 1.07099495 |
62 | MP0003806_abnormal_nucleotide_metabolis | 1.06657593 |
63 | MP0003828_pulmonary_edema | 1.06171832 |
64 | MP0004381_abnormal_hair_follicle | 1.06072109 |
65 | MP0003300_gastrointestinal_ulcer | 1.05546277 |
66 | MP0009333_abnormal_splenocyte_physiolog | 1.05413102 |
67 | MP0002254_reproductive_system_inflammat | 1.04923706 |
68 | * MP0005310_abnormal_salivary_gland | 1.04570570 |
69 | MP0005085_abnormal_gallbladder_physiolo | 1.02226682 |
70 | * MP0000689_abnormal_spleen_morphology | 1.00936299 |
71 | MP0009278_abnormal_bone_marrow | 0.99356550 |
72 | MP0004883_abnormal_blood_vessel | 0.96958935 |
73 | * MP0002429_abnormal_blood_cell | 0.96750241 |
74 | MP0002398_abnormal_bone_marrow | 0.96242735 |
75 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91957055 |
76 | MP0000703_abnormal_thymus_morphology | 0.90986812 |
77 | * MP0000249_abnormal_blood_vessel | 0.90972097 |
78 | MP0002132_abnormal_respiratory_system | 0.89595975 |
79 | MP0005390_skeleton_phenotype | 0.88956213 |
80 | MP0002166_altered_tumor_susceptibility | 0.88807268 |
81 | MP0003866_abnormal_defecation | 0.87884781 |
82 | MP0002006_tumorigenesis | 0.86707734 |
83 | MP0000858_altered_metastatic_potential | 0.85462620 |
84 | MP0004019_abnormal_vitamin_homeostasis | 0.84784487 |
85 | MP0000015_abnormal_ear_pigmentation | 0.84469842 |
86 | MP0005409_darkened_coat_color | 0.81680333 |
87 | * MP0000609_abnormal_liver_physiology | 0.81450181 |
88 | MP0004782_abnormal_surfactant_physiolog | 0.79973089 |
89 | * MP0002722_abnormal_immune_system | 0.79790402 |
90 | MP0005083_abnormal_biliary_tract | 0.79454172 |
91 | MP0002332_abnormal_exercise_endurance | 0.78465152 |
92 | MP0010329_abnormal_lipoprotein_level | 0.77964886 |
93 | MP0008874_decreased_physiological_sensi | 0.77662536 |
94 | MP0001727_abnormal_embryo_implantation | 0.76953496 |
95 | MP0003453_abnormal_keratinocyte_physiol | 0.76912242 |
96 | MP0002102_abnormal_ear_morphology | 0.76035427 |
97 | MP0008004_abnormal_stomach_pH | 0.76018619 |
98 | MP0003252_abnormal_bile_duct | 0.75970483 |
99 | MP0003091_abnormal_cell_migration | 0.75965450 |
100 | MP0005365_abnormal_bile_salt | 0.73570984 |
101 | MP0000569_abnormal_digit_pigmentation | 0.73171766 |
102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71348950 |
103 | MP0002118_abnormal_lipid_homeostasis | 0.69623478 |
104 | MP0004808_abnormal_hematopoietic_stem | 0.67883276 |
105 | MP0003186_abnormal_redox_activity | 0.67809758 |
106 | MP0000371_diluted_coat_color | 0.66055235 |
107 | MP0003795_abnormal_bone_structure | 0.65870495 |
108 | MP0001873_stomach_inflammation | 0.65271555 |
109 | MP0005535_abnormal_body_temperature | 0.64238522 |
110 | * MP0002136_abnormal_kidney_physiology | 0.64029778 |
111 | MP0009765_abnormal_xenobiotic_induced | 0.63834541 |
112 | MP0001986_abnormal_taste_sensitivity | 0.62224067 |
113 | MP0004742_abnormal_vestibular_system | 0.61409734 |
114 | MP0002396_abnormal_hematopoietic_system | 0.61394227 |
115 | MP0003045_fibrosis | 0.61255947 |
116 | MP0003329_amyloid_beta_deposits | 0.60930792 |
117 | MP0005332_abnormal_amino_acid | 0.60244245 |
118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59976953 |
119 | MP0009115_abnormal_fat_cell | 0.59526782 |
120 | MP0006054_spinal_hemorrhage | 0.59147773 |
121 | MP0001663_abnormal_digestive_system | 0.58974415 |
122 | MP0000767_abnormal_smooth_muscle | 0.57820806 |
123 | MP0003656_abnormal_erythrocyte_physiolo | 0.57234671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.05932711 |
2 | Systemic lupus erythematosus (HP:0002725) | 6.37365829 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.30438499 |
4 | Eczematoid dermatitis (HP:0000976) | 6.23410782 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.98590482 |
6 | Glomerulonephritis (HP:0000099) | 5.22910387 |
7 | Vacuolated lymphocytes (HP:0001922) | 4.54071953 |
8 | Abnormality of macrophages (HP:0004311) | 4.39226697 |
9 | Obstructive lung disease (HP:0006536) | 4.14761108 |
10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.14761108 |
11 | Recurrent skin infections (HP:0001581) | 4.10622751 |
12 | Complement deficiency (HP:0004431) | 4.03412024 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 3.99637415 |
14 | Axonal loss (HP:0003447) | 3.91181830 |
15 | Abnormality of complement system (HP:0005339) | 3.88033810 |
16 | Joint hemorrhage (HP:0005261) | 3.82369535 |
17 | Gingivitis (HP:0000230) | 3.78344779 |
18 | Stomatitis (HP:0010280) | 3.72971401 |
19 | Increased cerebral lipofuscin (HP:0011813) | 3.66830543 |
20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.49544464 |
21 | Thick nail (HP:0001805) | 3.39060234 |
22 | Nephritis (HP:0000123) | 3.38051204 |
23 | Prolonged partial thromboplastin time (HP:0003645) | 3.27109347 |
24 | Gastrointestinal infarctions (HP:0005244) | 3.22427806 |
25 | Dysostosis multiplex (HP:0000943) | 3.15539045 |
26 | Spontaneous hematomas (HP:0007420) | 3.15321949 |
27 | Myositis (HP:0100614) | 3.13488944 |
28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10484312 |
29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10484312 |
30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10484312 |
31 | Recurrent fungal infections (HP:0002841) | 3.10275950 |
32 | Orchitis (HP:0100796) | 3.08432653 |
33 | Optic neuritis (HP:0100653) | 3.05152346 |
34 | Retrobulbar optic neuritis (HP:0100654) | 3.05152346 |
35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.04646829 |
36 | Meningitis (HP:0001287) | 3.00005939 |
37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.92169476 |
38 | Disinhibition (HP:0000734) | 2.91688008 |
39 | Cellulitis (HP:0100658) | 2.90308314 |
40 | T lymphocytopenia (HP:0005403) | 2.87032129 |
41 | Myocardial infarction (HP:0001658) | 2.85214946 |
42 | Pustule (HP:0200039) | 2.80034155 |
43 | Vasculitis (HP:0002633) | 2.79889031 |
44 | Recurrent pneumonia (HP:0006532) | 2.73121323 |
45 | Abnormality of T cell number (HP:0011839) | 2.70590675 |
46 | Colitis (HP:0002583) | 2.70004606 |
47 | Prostate neoplasm (HP:0100787) | 2.61867462 |
48 | Recurrent viral infections (HP:0004429) | 2.61625290 |
49 | Increased IgE level (HP:0003212) | 2.61369156 |
50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56553980 |
51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56553980 |
52 | Osteomyelitis (HP:0002754) | 2.53251692 |
53 | Hepatosplenomegaly (HP:0001433) | 2.51228732 |
54 | Chest pain (HP:0100749) | 2.48981572 |
55 | Inflammation of the large intestine (HP:0002037) | 2.47911846 |
56 | Urticaria (HP:0001025) | 2.46831768 |
57 | Neurofibrillary tangles (HP:0002185) | 2.46708860 |
58 | Arterial thrombosis (HP:0004420) | 2.44484732 |
59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.44457048 |
60 | Amyloidosis (HP:0011034) | 2.43608193 |
61 | Recurrent bronchitis (HP:0002837) | 2.43459298 |
62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42753667 |
63 | Lymphopenia (HP:0001888) | 2.42418919 |
64 | Recurrent sinusitis (HP:0011108) | 2.42002417 |
65 | Mutism (HP:0002300) | 2.39496145 |
66 | Gingival bleeding (HP:0000225) | 2.37964079 |
67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.36829941 |
68 | Mucopolysacchariduria (HP:0008155) | 2.36829941 |
69 | Gangrene (HP:0100758) | 2.35335877 |
70 | Agammaglobulinemia (HP:0004432) | 2.34568727 |
71 | Restrictive lung disease (HP:0002091) | 2.33654302 |
72 | Peripheral demyelination (HP:0011096) | 2.32445695 |
73 | Abnormality of the pleura (HP:0002103) | 2.31907200 |
74 | Pulmonary infiltrates (HP:0002113) | 2.30836228 |
75 | Anorexia (HP:0002039) | 2.28449277 |
76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28318196 |
77 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28318196 |
78 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28318196 |
79 | Purpura (HP:0000979) | 2.28187353 |
80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25933346 |
81 | Increased IgM level (HP:0003496) | 2.25495009 |
82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.22458224 |
83 | Interstitial pulmonary disease (HP:0006530) | 2.22237685 |
84 | Abnormality of T cells (HP:0002843) | 2.21681538 |
85 | Periodontitis (HP:0000704) | 2.20446818 |
86 | Hematochezia (HP:0002573) | 2.18433876 |
87 | Panhypogammaglobulinemia (HP:0003139) | 2.18415249 |
88 | Prolonged bleeding time (HP:0003010) | 2.17361200 |
89 | Increased serum ferritin (HP:0003281) | 2.17337409 |
90 | Pulmonary embolism (HP:0002204) | 2.16676949 |
91 | Bone pain (HP:0002653) | 2.14951891 |
92 | IgM deficiency (HP:0002850) | 2.14548839 |
93 | Polyneuropathy (HP:0001271) | 2.14497042 |
94 | Gastrointestinal inflammation (HP:0004386) | 2.14125302 |
95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.13817990 |
96 | Basal ganglia calcification (HP:0002135) | 2.13723374 |
97 | Autoimmune thrombocytopenia (HP:0001973) | 2.13355236 |
98 | Chronic otitis media (HP:0000389) | 2.11318914 |
99 | Prolonged neonatal jaundice (HP:0006579) | 2.09223147 |
100 | Deep venous thrombosis (HP:0002625) | 2.08454009 |
101 | Abnormality of the peritoneum (HP:0002585) | 2.08273359 |
102 | Loss of speech (HP:0002371) | 2.07369352 |
103 | Agnosia (HP:0010524) | 2.07059640 |
104 | Epistaxis (HP:0000421) | 2.04491999 |
105 | Keratoconjunctivitis sicca (HP:0001097) | 2.03585238 |
106 | Gastrointestinal stroma tumor (HP:0100723) | 2.01844434 |
107 | Premature loss of primary teeth (HP:0006323) | 1.98084130 |
108 | Leukocytosis (HP:0001974) | 1.96897696 |
109 | Upper motor neuron abnormality (HP:0002127) | 1.96251145 |
110 | Hemoptysis (HP:0002105) | 1.95077346 |
111 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93876904 |
112 | Sepsis (HP:0100806) | 1.92999808 |
113 | Thoracic kyphosis (HP:0002942) | 1.92718149 |
114 | Emphysema (HP:0002097) | 1.92250955 |
115 | Abnormality of the prostate (HP:0008775) | 1.91943515 |
116 | Hypergammaglobulinemia (HP:0010702) | 1.91808824 |
117 | Pathologic fracture (HP:0002756) | 1.91714134 |
118 | Xanthomatosis (HP:0000991) | 1.91502097 |
119 | Glomerulopathy (HP:0100820) | 1.91346265 |
120 | White forelock (HP:0002211) | 1.90280102 |
121 | Abnormality of the lumbar spine (HP:0100712) | 1.87572638 |
122 | Parakeratosis (HP:0001036) | 1.87389155 |
123 | Encephalitis (HP:0002383) | 1.86249669 |
124 | Keratoconjunctivitis (HP:0001096) | 1.86212460 |
125 | Petechiae (HP:0000967) | 1.86209602 |
126 | Menorrhagia (HP:0000132) | 1.86062869 |
127 | Chronic diarrhea (HP:0002028) | 1.85897882 |
128 | Patchy hypopigmentation of hair (HP:0011365) | 1.79527061 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.73512056 |
2 | * BLK | 4.14834848 |
3 | IRAK4 | 3.55721684 |
4 | MAP3K14 | 3.53176240 |
5 | IRAK3 | 3.20225135 |
6 | MAP4K1 | 2.82663460 |
7 | PBK | 2.71443942 |
8 | TYK2 | 2.46325227 |
9 | PRPF4B | 2.31710540 |
10 | TGFBR2 | 2.30696952 |
11 | EPHB1 | 2.23929677 |
12 | MAP3K13 | 2.21748091 |
13 | TAOK3 | 2.20166918 |
14 | TBK1 | 2.12037419 |
15 | TXK | 2.08443798 |
16 | FES | 2.07239049 |
17 | GRK7 | 2.06491668 |
18 | FGR | 2.05013975 |
19 | CSK | 1.95291516 |
20 | CSF1R | 1.81974222 |
21 | KIT | 1.74560640 |
22 | JAK1 | 1.71650122 |
23 | IKBKB | 1.69869798 |
24 | ERN1 | 1.61848412 |
25 | CLK1 | 1.59391217 |
26 | IKBKE | 1.58598420 |
27 | IRAK1 | 1.50587631 |
28 | MAP3K3 | 1.45415767 |
29 | * LYN | 1.39546228 |
30 | TAOK1 | 1.37377524 |
31 | SYK | 1.37180098 |
32 | TEC | 1.36044340 |
33 | BTK | 1.34337110 |
34 | GRK1 | 1.33219876 |
35 | PKN1 | 1.32555004 |
36 | HCK | 1.31708355 |
37 | MAP3K11 | 1.30533452 |
38 | INSRR | 1.26446768 |
39 | JAK3 | 1.23955942 |
40 | TAOK2 | 1.23682522 |
41 | STK10 | 1.22699678 |
42 | LCK | 1.18806254 |
43 | MAP3K1 | 1.17986904 |
44 | IRAK2 | 1.16456726 |
45 | CAMK1D | 1.15838800 |
46 | SIK2 | 1.15524735 |
47 | NEK9 | 1.11045252 |
48 | BMPR2 | 1.10047851 |
49 | ADRBK2 | 1.09627864 |
50 | MKNK2 | 1.06983726 |
51 | CDC42BPA | 1.06189738 |
52 | YES1 | 1.05854091 |
53 | JAK2 | 1.02192910 |
54 | PIK3CG | 1.02158708 |
55 | MST1R | 0.98290514 |
56 | CAMKK2 | 0.94701644 |
57 | NME2 | 0.94637301 |
58 | PRKCQ | 0.91252703 |
59 | CAMK1G | 0.90928274 |
60 | SIK3 | 0.90496566 |
61 | EIF2AK2 | 0.87644991 |
62 | TNIK | 0.87340744 |
63 | MST4 | 0.84981388 |
64 | ZAP70 | 0.82458242 |
65 | KSR2 | 0.81963538 |
66 | MATK | 0.81923139 |
67 | ITK | 0.81836748 |
68 | ABL2 | 0.77620835 |
69 | PRKCD | 0.74255847 |
70 | STK4 | 0.73704473 |
71 | CASK | 0.71703332 |
72 | PDPK1 | 0.70388964 |
73 | MAP3K5 | 0.67481220 |
74 | TRIB3 | 0.67249839 |
75 | MARK3 | 0.66916502 |
76 | MAPK15 | 0.66599979 |
77 | ABL1 | 0.65552524 |
78 | NEK6 | 0.65476369 |
79 | KDR | 0.64009290 |
80 | FGFR3 | 0.63235853 |
81 | MARK2 | 0.63076461 |
82 | ACVR1B | 0.62405537 |
83 | * FYN | 0.59497338 |
84 | PDK1 | 0.58905501 |
85 | PRKAA2 | 0.58431650 |
86 | MAPK7 | 0.58357382 |
87 | EPHA3 | 0.58232379 |
88 | NUAK1 | 0.57940390 |
89 | CHUK | 0.57264686 |
90 | PIK3CA | 0.57128895 |
91 | HIPK2 | 0.53699036 |
92 | EGFR | 0.53269608 |
93 | BMX | 0.52094073 |
94 | GRK6 | 0.51981468 |
95 | MAP2K3 | 0.51854490 |
96 | FGFR4 | 0.51590863 |
97 | DDR2 | 0.50455682 |
98 | NLK | 0.50327772 |
99 | SGK3 | 0.49211423 |
100 | STK39 | 0.48996350 |
101 | PIM1 | 0.47145331 |
102 | RPS6KC1 | 0.46841543 |
103 | RPS6KL1 | 0.46841543 |
104 | MAPK12 | 0.45504379 |
105 | PIM2 | 0.44680921 |
106 | TRPM7 | 0.43328004 |
107 | OXSR1 | 0.42907303 |
108 | MAP3K10 | 0.41371951 |
109 | SGK2 | 0.41210031 |
110 | MAP3K6 | 0.40813200 |
111 | TESK2 | 0.40635929 |
112 | RIPK1 | 0.40391662 |
113 | IGF1R | 0.40362281 |
114 | CDK4 | 0.39461671 |
115 | RPS6KA6 | 0.38850339 |
116 | MAPK4 | 0.38641321 |
117 | MAP2K6 | 0.38397911 |
118 | TNK2 | 0.38350723 |
119 | MOS | 0.38342724 |
120 | PRKD2 | 0.38145112 |
121 | MAPKAPK2 | 0.37670936 |
122 | BMPR1B | 0.37275650 |
123 | LRRK2 | 0.36812680 |
124 | CAMKK1 | 0.36716522 |
125 | INSR | 0.35455410 |
126 | DMPK | 0.35094931 |
127 | CDK6 | 0.33560590 |
128 | GSK3A | 0.33461880 |
129 | MAP3K2 | 0.32938967 |
130 | MAPK11 | 0.32589852 |
131 | PRKD1 | 0.32509390 |
132 | DAPK2 | 0.30170471 |
133 | MAP2K2 | 0.30056505 |
134 | ERBB4 | 0.29607709 |
135 | CAMK4 | 0.28815645 |
136 | MAP3K8 | 0.28195585 |
137 | SRC | 0.26205145 |
138 | PRKCE | 0.25879994 |
139 | PTK6 | 0.24543952 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.84947861 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.87236759 |
3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84869528 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48453472 |
5 | Pertussis_Homo sapiens_hsa05133 | 2.35296769 |
6 | Lysosome_Homo sapiens_hsa04142 | 2.33723483 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31246414 |
8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22312440 |
9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19351911 |
10 | Malaria_Homo sapiens_hsa05144 | 2.15787279 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12993899 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05017737 |
13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00357445 |
14 | * Tuberculosis_Homo sapiens_hsa05152 | 1.95483144 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84825825 |
16 | Asthma_Homo sapiens_hsa05310 | 1.82416848 |
17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75533207 |
18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72370473 |
19 | Legionellosis_Homo sapiens_hsa05134 | 1.70684478 |
20 | * Phagosome_Homo sapiens_hsa04145 | 1.63382729 |
21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61532392 |
22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51185523 |
23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.50255004 |
24 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49587209 |
25 | Salmonella infection_Homo sapiens_hsa05132 | 1.47371872 |
26 | Allograft rejection_Homo sapiens_hsa05330 | 1.42454662 |
27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40634738 |
28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38966059 |
29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38166042 |
30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36901660 |
31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34169278 |
32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.31143875 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29749652 |
34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25357421 |
35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24305261 |
36 | Prion diseases_Homo sapiens_hsa05020 | 1.22488640 |
37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21395244 |
38 | * Measles_Homo sapiens_hsa05162 | 1.16999031 |
39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11268023 |
40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10568843 |
41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06317895 |
42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05418399 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03675187 |
44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01889767 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01479075 |
46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96868808 |
47 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95103364 |
48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93256596 |
49 | Influenza A_Homo sapiens_hsa05164 | 0.92182968 |
50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91065324 |
51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90785130 |
52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90511289 |
53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89998822 |
54 | ABC transporters_Homo sapiens_hsa02010 | 0.89375679 |
55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84681790 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82770151 |
57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79289128 |
58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77401142 |
59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76950018 |
60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76204560 |
61 | Amoebiasis_Homo sapiens_hsa05146 | 0.73412063 |
62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72685258 |
63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72405320 |
64 | Peroxisome_Homo sapiens_hsa04146 | 0.72112799 |
65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71942864 |
66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71689537 |
67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69154444 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68851415 |
69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64975973 |
70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63928107 |
71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63926566 |
72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63666884 |
73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62605049 |
74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61868327 |
75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61079455 |
76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60872262 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60231929 |
78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59861292 |
79 | Apoptosis_Homo sapiens_hsa04210 | 0.59245833 |
80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59101053 |
81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58481121 |
82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58117931 |
83 | Platelet activation_Homo sapiens_hsa04611 | 0.57533455 |
84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56097838 |
85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54484832 |
86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53167559 |
87 | Shigellosis_Homo sapiens_hsa05131 | 0.52750998 |
88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52038651 |
89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49166370 |
90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48950084 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48869931 |
92 | Hepatitis C_Homo sapiens_hsa05160 | 0.48581762 |
93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47926453 |
94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47575508 |
95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47353335 |
96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47339621 |
97 | Mineral absorption_Homo sapiens_hsa04978 | 0.45585676 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44047538 |
99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43268241 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42870127 |
101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42013947 |
102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41886784 |
103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41608338 |
104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40838381 |
105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38959038 |
106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38766579 |
107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38480521 |
108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37358690 |
109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36730056 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.36552360 |
111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35780457 |
112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34939134 |
113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34535996 |
114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33440382 |
115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.33108286 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.32779272 |
117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32778356 |
118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32449868 |
119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31375959 |
120 | Hepatitis B_Homo sapiens_hsa05161 | 0.29809278 |
121 | Bladder cancer_Homo sapiens_hsa05219 | 0.29454338 |
122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28376111 |
123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28019777 |
124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26115363 |
125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25100408 |
126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24388585 |
127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23867415 |
128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22948520 |
129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21925352 |
130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21233786 |
131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21158183 |
132 | Prostate cancer_Homo sapiens_hsa05215 | 0.16846613 |
133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.14622667 |